9 Meters Biopharma Inc

NASDAQ:NMTR   2:12:05 PM EDT
0.48
+0.02 (+4.96%)
Earnings Announcements

9 Meters Biopharma Q4 Loss Per Share $0.04

Published: 03/23/2022 11:17 GMT
9 Meters Biopharma Inc (NMTR) - Q4 Loss per Share $0.04.
9 Meters Biopharma - Year-ending Cash of $47.0 Million is Expected to Fund Ongoing Clinical Programs and Business Operations Into Q2 2023.
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$0.04

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.04

More details on our Analysts Page.